Rick Doblin has been one of the few medical doctors in the United States, or actually make that more or less anywhere in the developed world, willing to stick his neck out and conduct clinical trials of psychedelic drugs.
His work has been variously profiled by the alternative press (including, of course, Under The Influence: The Disinformation Guide to Drugs), but it seems that his time may finally have come for some mainstream acceptance. Benedict Carey profiles the work of Doblin’s Multidisciplinary Association for Psychedelic Studies (MAPS) organization for the New York Times:
Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it.
The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection.






Imagine 
A documentary maker
The